Hostname: page-component-848d4c4894-x5gtn Total loading time: 0 Render date: 2024-06-02T11:54:13.364Z Has data issue: false hasContentIssue false
  • English
  • Français

Use of the anticonvulsant carbamazepine in primary and secondary affective illness: clinical and theoretical implications1

Published online by Cambridge University Press:  09 July 2009

R. M. Post
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Editorial
Information
Psychological Medicine , Volume 12 , Issue 4 , November 1982 , pp. 701 - 704
Copyright
Copyright © Cambridge University Press 1982

References

Albright, P. S. & Burnham, W. M. (1980). Development of a new pharmacological seizure model: effects of anticonvulsants on cortical- and amygdala-kindled seizures in the rat. Epilepsia 21, 681–689.CrossRefGoogle ScholarPubMed
Babington, R. G. & Horovitz, Z. P. (1973). Neuropharmacology of SQ 10,996, a compound with several therapeutic indications. Archives Internationale de Pharmacodynamie 202, 106–118.Google ScholarPubMed
Ballenger, J. C. & Post, R. M. (1978). Therapeutic effects of carbamazepine in affective illness: a preliminary report. Communications in Psychopharmacology 2, 159–175.Google ScholarPubMed
Ballenger, J. C. & Post, R. M. (1980). Carbamazepine (Tegretol) in manic-depressive illness: a new treatment. American Journal of Psychiatry 137, 782–790.Google ScholarPubMed
Bernasconi, R. & Martin, P. (1979). Effects of antileptic drugs on the GABA turnover rate. Naunyn–Schmiedebergs Archiv für experimentalle Pathologie und Pharmakologie (suppl) 307, R63, Abstract 251.Google Scholar
Berrettini, W. H., Post, R. M., Worthington, E. K. & Casper, J. B. (1981). Human platelet vasopressin receptors. Life Sciences 30, 425–432.CrossRefGoogle Scholar
Dalby, M. A. (1971). Antiepileptic and psychotropic effect of carbamazepine (Tegretol) in the treatment of psychomotor epilepsy. Epilepsia 12, 325–334.CrossRefGoogle ScholarPubMed
Dalby, M. A. (1975). Behavioral effects of carbamazepine. In Complex Partial Seizures and Their Treatment: Advances in Neurology, Vol. 11 (ed. Penry, J. K. and Daly, D. D.), pp. 331–343. Raven Press: New York.Google Scholar
Dodrill, C. B. & Troupin, A. S. (1977). Psychotropic effects of carbamazepine in epilepsy: a double-blind comparison with phenytoin. Neurology 27, 1023–1028.CrossRefGoogle ScholarPubMed
Emrich, H. M., von Zerssen, D., Kissling, W., Moller, H.-J. & Windorfer, A. (1980). Effect of sodium valproate in mania. The GABA-hypothesis of affective disorders. Archiv für Psychiatrie und Nervenkrankheiten 229, 1–16.CrossRefGoogle ScholarPubMed
Folks, D.C., King, L. D., Dowdy, S. B., Petrie, W. M., Jack, R. A., Koomen, J. C., Swenson, B. R. & Edwards, P. (1982). Carbamazepine treatment of selected affectively disordered inpatients. American Journal of Psychiatry 139, 115–117.Google ScholarPubMed
Ghose, K. (1978). Effect of carbamazepine in polyuria associated with lithium therapy. Pharmakopsychiatrie und Neuropsychopharmakologie 11, 241–245.CrossRefGoogle ScholarPubMed
Koella, W. P., Levin, P. & Baltzer, V. (1975). The pharmacology of carbamazepine and some other anti-epileptic drugs. In Epileptic Seizures – Behavior – Pain (ed. Birkmayer, W.), pp. 32–50. Hans Huber: Bern.Google Scholar
Kukopulos, A., Reginaldi, D., Laddomada, P., Floris, G., Serra, G. & Tondo, L. (1980). Course of the manic-depressive cycle and changes caused by treatments. Pharmakopsychiatrie 13, 156–167.CrossRefGoogle Scholar
Maffly, R. H. (1977). Diabetes insipidus. In Disturbances in Body Fluid Osmolality (ed. Andredi, T. E.), pp. 285–308. American Physiological Society: Bethesda, MD.Google Scholar
Okuma, T., Kishimoto, A., Inouye, K., Matsumoto, H., Ogura, A., Matsushita, T., Naklao, T. & Ogura, C. (1973). Anti-manic and prophylactic effects of carbamazepine on manic-depressive psychosis. Folia psychiatrica et neurologica Japonica 27, 283–297.Google ScholarPubMed
Okuma, T., Inanaga, K., Otsuki, S., Sarai, K., Takahashi, R., Hazama, H., Mori, A. & Watanabe, M. (1979). Comparison of the antimanic efficacy of carbamazepine and chlorpromazine: a double-blind controlled study. Psychopharmacology 66, 211–217.CrossRefGoogle ScholarPubMed
Okuma, T., Inanaga, K., Otsuki, S., Sarai, K., Takahashi, R., Hazama, H., Mori, A. & Watanabe, M. (1981). A preliminary double-blind study of the efficacy of carbamazepine in prophylaxis of manic-depressive illness. Psychopharmacology 73, 95–96.CrossRefGoogle ScholarPubMed
Penry, J. K. & Daly, D. D. (1975). Complex Partial Seizures and Their Treatment: Advances in Neurology, Vol. 11. Raven Press: New York.Google Scholar
Piscotta, A. V. (1975). Hematologic toxicity of carbamazepine. In Complex Partial Seizures and their Treatment: Advances in Neurology, Vol. 11 (ed. Penry, J. K. and Daly, D. D.), pp. 355 366. Raven Press: New York.Google Scholar
Post, R. M., Ballenger, J. C., Reus, V. I., Lake, C. R., Lerner, P. & Bunney, W. E. Jr (1978). Effects of carbamazepine in mania and depression.Presented at the scientific Proceedings of the 131st Annual Meeting of the American Psychiatric Association,Atlanta,May 1978, New Research Abstracts No. 7.Google Scholar
Post, R. M., Ballenger, J. C., Hare, T. A. & Bunney, W. E. Jr (1980). Lack of effect of carbamazepine on gamma-aminobutyric acid levels in cerebrospinal fluid. Neurology 30, 1008–1011.CrossRefGoogle ScholarPubMed
Post, R. M., Pickar, D., Naber, D., Ballenger, J. C., Uhde, T. W. & Bunney, W. E. Jr (1981 a). Effect of carbamazepine on CSF opioid activity: relationship to antidepressant response. Psychiatry Research 5, 59–61.CrossRefGoogle ScholarPubMed
Post, R. M., Putnam, F. W. & Contel, N. R.. (1981 b). Electroconvulsive shock inhibits amygdala kindling.Society for Neuroscience Abstracts, 11th Annual Meeting, Abstract No. 187.13, 7, 587.Google Scholar
Post, R. M., Ballenger, J. C., Uhde, T. W., Chatterji, D. C. & Bunney, W. E. Jr (1982 a). Efficacy of the temporal-lobe limbic anticonvulsant carbamazepine in manic and depressive illness.In Proceedings of the 3rd World Congress of Biological Psychiatry,Stockholm,June 1981 (ed. Jansson, B., Perris, C. and Struwe, G.). Elsevier: Amsterdam.Google Scholar
Post, R. M., Ballenger, J. C., Uhde, T. W. & Bunney, W. E. Jr (1982 b). Efficacy of carbamazepine in manic-depressive illness: implications for underlying mechanisms. In Neurobiology of the Mood Disorders (ed. Post, R. M. and Ballenger, J. C.), Williams and Wilkins: Baltimore (in the press).Google Scholar
Purdy, R. E., Julien, R. M., Fairhurst, A. S. & Terry, M. D. (1977). Effect of carbamazepine on the in vitro uptake and release of norepinephrine in adrenergic nerves of rabbit aorta and in whole brain synaptosomes. Epilepsia 18, 251–257.CrossRefGoogle ScholarPubMed
Rubinow, D. R., Gold, P., Post, R. M., Ballenger, J. C. & Reichlin, S. (1982). Somatostatin in affective illness and normal volunteers. In Neurobiology of the Mood Disorders (ed. Post, R. M. and Ballenger, J. C.). Williams and Wilkins: Baltimore (in the press).Google Scholar
Stevens, J. R., Bigelow, L., Denney, D., Lipkin, J., Livermore, A., Ranscher, F. & Wyatt, R. J. (1979). Telemetered EEG-EOG during psychiatric behaviors of schizophrenics. Archives of General Psychiatry 36, 251–262.CrossRefGoogle Scholar
Stephens, W. P., Coe, J. Y. & Baylis, P. H. (1978). Plasma arginine vasopressin concentrations and antidiuretic action of carbamazepine. British Medical Journal i, 1445–1447.CrossRefGoogle Scholar
Takezaki, H. & Hanaoka, M. (1971). The use of carbamazepine (Tegretol) in the control of manic-depressive psychosis and other manic, depressive states (in Japanese). Sheishin-igaku 13, 173–183.Google Scholar
Thompson, P., Huppert, F. & Trimble, M. (1980). Anticonvulsant drugs, cognitive function and memory. Acta neurologica scandinavica (suppl 80) 62, 75–81.CrossRefGoogle Scholar
Wada, J. A. (1977). Pharmacological prophylaxis in the kindling model of epilepsy. Archives of Neurology 34, 389–395.CrossRefGoogle ScholarPubMed
Wada, J. A., Sato, M., Wake, A., Green, J. R. & Troupin, A. S. (1976). Prophylactic effects of phenytoin, phenobarbital, and carbamazepine examined in kindled cat preparation. Archives of Neurology 33, 426–434.CrossRefGoogle Scholar
Wales, J. K. (1975). Treatment of diabetes insipidus with carbamazepine. Lancet ii, 948–951.CrossRefGoogle Scholar